These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21855558)
1. Glucocorticoids exert context-dependent effects on cells of the joint in vitro. Madsen SH; Andreassen KV; Christensen ST; Karsdal MA; Sverdrup FM; Bay-Jensen AC; Henriksen K Steroids; 2011 Dec; 76(13):1474-82. PubMed ID: 21855558 [TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492 [TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896 [TBL] [Abstract][Full Text] [Related]
5. The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells. Kósa JP; Kis A; Bácsi K; Balla B; Nagy Z; Takács I; Speer G; Lakatos P Bone; 2011 May; 48(5):1052-7. PubMed ID: 21277400 [TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. Okamoto M; Murai J; Yoshikawa H; Tsumaki N J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Murakami T; Yamamoto M; Ono K; Nishikawa M; Nagata N; Motoyoshi K; Akatsu T Biochem Biophys Res Commun; 1998 Nov; 252(3):747-52. PubMed ID: 9837778 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073 [TBL] [Abstract][Full Text] [Related]
9. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639 [TBL] [Abstract][Full Text] [Related]
10. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Oestergaard S; Sondergaard BC; Hoegh-Andersen P; Henriksen K; Qvist P; Christiansen C; Tankó LB; Karsdal MA Arthritis Rheum; 2006 Aug; 54(8):2441-51. PubMed ID: 16871544 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of glucocorticoid action in bone cells. Delany AM; Dong Y; Canalis E J Cell Biochem; 1994 Nov; 56(3):295-302. PubMed ID: 7876321 [TBL] [Abstract][Full Text] [Related]
12. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
13. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation. van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698 [TBL] [Abstract][Full Text] [Related]
15. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687 [TBL] [Abstract][Full Text] [Related]
17. Hydrolyzed collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: an in vitro and in vivo study. Guillerminet F; Beaupied H; Fabien-Soulé V; Tomé D; Benhamou CL; Roux C; Blais A Bone; 2010 Mar; 46(3):827-34. PubMed ID: 19895915 [TBL] [Abstract][Full Text] [Related]
18. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. Weinstein RS; Chen JR; Powers CC; Stewart SA; Landes RD; Bellido T; Jilka RL; Parfitt AM; Manolagas SC J Clin Invest; 2002 Apr; 109(8):1041-8. PubMed ID: 11956241 [TBL] [Abstract][Full Text] [Related]
19. Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis. Weitoft T; Larsson A; Saxne T; Rönnblom L Ann Rheum Dis; 2005 Dec; 64(12):1750-3. PubMed ID: 15843449 [TBL] [Abstract][Full Text] [Related]
20. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]